Application 074654

Type: ANDA
Sponsor: SANDOZ

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	TABLET;ORAL	385MG;30MG;25MG	No	No
002	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	TABLET;ORAL	770MG;60MG;50MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A074654-001	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	385MG;30MG;25MG	TABLET / ORAL			1996-12-31
A074654-002	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770MG;60MG;50MG	TABLET / ORAL			1996-12-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2022-10-28 04:53 UTC	2022-10	A074654-001	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	385MG;30MG;25MG	TABLET / ORAL	1996-12-31	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A074654-002	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	770MG;60MG;50MG	TABLET / ORAL	1996-12-31	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A074654-001	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	385MG;30MG;25MG	TABLET / ORAL	1996-12-31	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A074654-002	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	770MG;60MG;50MG	TABLET / ORAL	1996-12-31	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A074654-001	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	385MG;30MG;25MG	TABLET / ORAL	1996-12-31	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A074654-002	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	770MG;60MG;50MG	TABLET / ORAL	1996-12-31	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A074654-001	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	385MG;30MG;25MG	TABLET / ORAL	1996-12-31	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A074654-002	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	770MG;60MG;50MG	TABLET / ORAL	1996-12-31	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A074654-002	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A074654-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A074654-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A074654-002	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 1 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
21695-726	Orphenadrine Citrate, Aspirin and Caffeine	Orphenadrine Citrate, Aspirin and Caffeine	Rebel Distributors Corp	ANDA	Current